BioCentury | Apr 7, 2008
Company News

CG Therapeutics, University of Washington deal

...CG will own the mAbs and plans to use them in conjunction with its CG201...
BioCentury | Mar 10, 2008
Emerging Company Profile

CG Therapeutics: Hormone neutralizer

...lead product is CG201 , a peptide-based vaccine with a proprietary delivery system. "Inoculation with CG201...
...the adult body, Lyon noted targeting and neutralizing hCG has no effect on healthy tissues. "CG201...
...and many new cancer therapies," he said. The company licensed exclusive, worldwide rights to the CG201...
Items per page:
1 - 2 of 2